|
rdfs:label
|
"Vemurafenib"@de
"Vemurafenib"@es
"Vemurafenib"@it
"Vemurafenib"@nb
"Vemurafenib"@sh
"Vemurafenib"@sr
"Vemurafenib"@id
"vemurafenib"@en
"vemurafenib"@ast
"vemurafenib"@ca
"vemurafenib"@fr
"vemurafenib"@hu
"vemurafenib"@nl
"vemurafenib"@nn
"vemurafenib"@sl
"vemurafenib"@sv
"vemurafenibe"@pt
"wemurafenib"@pl
"вемурафениб"@ru
"вемурафеніб"@uk
"вэмурафэніб"@be-tarask
"فيميورافينيب"@ar
"ومورافنیب"@fa
"ଭେମୁରାଫେନିବ"@or
"వెమురాఫెనిబ్"@te
"പി.എൽ.എക്സ്. 4032"@ml
"ベムラフェニブ"@ja
"維莫非尼"@zh-hant
"维莫非尼"@zh
"维莫非尼"@zh-cn
"维莫非尼"@zh-hans
|
|
skos:altLabel
|
"BRAF(V600E) Kinase Inhibitor RO5185426"@en
"N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide"@en
"N-{3-[3-Karbonyl-5-(4-klorofenyl)-1H-pyrrolo[2,3-b]pyridin]-2,4-difluorofenyl}propan-1-sulfonamid"@sv
"PLX 4032"@en
"PLX4032"@ast
"PLX4032"@de
"PLX4032"@en
"PLX4032"@fr
"PLX4032"@ml
"PLX4032"@sv
"RG7204"@ast
"RG7204"@en
"RG7204"@sv
"Vemurafenib"@en
"Zelboraf"@en
"Zelboraf"@sv
"Zelboraf®"@ast
"Zelboraf®"@en
"അർബുദ ചികിത്സ"@ml
"പീ .എൽ .എക്സ് 4032"@ml
"ヴェムラフェニブ"@ja
"佐博伏®"@zh
"维罗非尼"@zh
|
|
schema:description
|
"Kompozé chimik"@gcr
"cheemesch Verbindung"@lb
"chemical compound"@en
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"composito chimic"@ia
"compositum chemicum"@la
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"conposto chìmego"@vec
"cumpostu chìmicu"@scn
"cyfansoddyn cemegol"@cy
"gemyske ferbining"@fy
"kediad kimiek"@br
"keemiline ühend"@et
"kemia kombinaĵo"@eo
"kemiala kompozajo"@io
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kemisk förening"@sv
"kimyasal bileşik"@tr
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"payvastagii khimiyaviy"@tg-latn
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"χημική ένωση"@el
"пайвастагии химиявӣ"@tg-cyrl
"хемиско соединение"@mk
"химическое соединение"@ru
"химично съединение"@bg
"хімічна сполука"@uk
"хімічнае злучэнне"@be
"хімічнае злучэньне"@be-tarask
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ఔషధం"@te
"രാസസംയുക്തം"@ml
"化合物"@yue
"化合物"@zh
"化合物"@zh-cn
"化合物"@zh-hans
"化合物"@zh-hant
"化合物"@zh-hk
"化合物"@zh-sg
"化合物"@zh-tw
"化合物"@zh-mo
|
|
schema:dateModified
|
"2026-11-04T08:55:11+00:00"^^xsd:dateTime
|
|
schema:version
|
2564626650
|
|
wikibase:identifiers
|
47
|
|
wikibase:sitelinks
|
20
|
|
wikibase:statements
|
74
|
|
p:P10245
|
wd:statement/Q423111-9e65a57e-45da-4a7f-cf7c-ecc30ba0b6e7
|
|
p:P10283
|
wd:statement/Q423111-99F20C1D-1A6C-453E-BB15-3DC3D342AD79
|
|
p:P11089
|
wd:statement/Q423111-3F760788-D56E-4F58-AC8A-A27F9D4FCC5C
|
|
p:P11143
|
wd:statement/Q423111-EE4C290D-2ACC-4972-A487-EDE0B17EDDDA
|
|
p:P11198
|
wd:statement/Q423111-8D53B5BC-B59B-453F-88F2-BA76C8338693
|
|
p:P11199
|
wd:statement/Q423111-562A096D-18AF-466F-BBE5-E29CB9E8D150
|
|
p:P117
|
wd:statement/Q423111-0FF2C80B-52A2-4EAF-9CB6-842F7FBDB5AF
|
|
p:P129
|
wd:statement/Q423111-5DEA3079-3B8B-45B6-8873-6BE117715AA2
|
|
wd:statement/Q423111-CDBD6C7A-D43F-4C1C-BE38-B47D7C047130
|
|
p:P1579
|
wd:statement/Q423111-46FE8455-4CFD-4EBB-A9BB-54740D41805A
|
|
p:P1617
|
wd:statement/Q423111-56EF5429-A75C-4307-8534-1A4772784F3F
|
|
p:P2057
|
wd:statement/Q423111-0C9E0C8D-D562-4DD9-BB76-8169F7467B68
|
|
p:P2062
|
wd:statement/Q423111-791A591C-D049-43F2-BC5D-CA1367AF3BD1
|
|
p:P2067
|
wd:statement/Q423111-E545B5D0-51CC-4A29-8D52-ECBA1A82B4FC
|
|
p:P2115
|
wd:statement/Q423111-AEB90349-29F1-4162-A735-9600CCBDC62E
|
|
p:P2175
|
wd:statement/Q423111-595EAFE5-120E-4F7B-A53E-AC58150209F5
|
|
wd:statement/Q423111-662D8DF2-F6FD-48F6-A325-2DEB8E5A9EAF
|
|
wd:statement/Q423111-852342C7-27AD-4666-835B-709945C77A4F
|
|
wd:statement/Q423111-A7EE85AD-2287-46F2-B90A-EDCC6AF0E3A9
|
|
wd:statement/Q423111-AA541879-4065-4622-980A-16764A57CA80
|
|
p:P2275
|
wd:statement/Q423111-E119E09C-A49B-4614-AA7A-06D21B481833
|
|
p:P231
|
wd:statement/Q423111-18B00443-1B63-4E71-A27F-BDC3602A6F7A
|
|
p:P232
|
wd:statement/Q423111-52508c26-4865-52c2-eac1-2318f4fdd0d7
|
|
p:P233
|
wd:statement/Q423111-DB9A3208-C7FF-406A-9F09-F722E5CD4B38
|
|
p:P234
|
wd:statement/Q423111-71533513-D9CA-4D89-A633-880BC9E909EA
|
|
p:P235
|
wd:statement/Q423111-2AD1466C-2FA0-4DAE-B797-08EFFAEE3F06
|
|
p:P2566
|
wd:statement/Q423111-7eced396-4a33-45fd-0347-9ac01bcdc4e6
|
|
p:P267
|
wd:statement/Q423111-8E0BF238-55AE-4428-8522-4F542C1AF948
|
|
p:P274
|
wd:statement/Q423111-0743C719-DB60-4B4C-ACF7-3AC112F8EF6E
|
|
p:P279
|
wd:statement/Q423111-6CCF585E-D6FE-4905-97BC-79870CA49CE7
|
|
p:P2868
|
wd:statement/Q423111-57D7F6AA-2EDC-4828-9EB8-51E6206942CD
|
|
wd:statement/Q423111-AD130F95-FAF2-402C-B1BB-6FA3A80175BC
|
|
wd:statement/Q423111-C1BA75EF-FAF6-4C50-A6BA-6D08FCD43E8E
|
|
wd:statement/Q423111-a86624df-46eb-02cb-0ca0-e53dafb007a5
|
|
p:P2877
|
wd:statement/Q423111-f005a602-4e4e-1673-ecd2-8d60ba92d763
|
|
p:P2892
|
wd:statement/Q423111-a39e2df3-4d7e-3718-7b21-cc57564d5e42
|
|
p:P31
|
wd:statement/Q423111-CE0D920C-BE8C-45A9-85C3-A229A61A6AF9
|
|
p:P3117
|
wd:statement/Q423111-DFB6DAAE-A4C3-4D3D-A6AA-A9D76E0BE0EE
|
|
p:P3345
|
wd:statement/Q423111-442b1469-410a-f43c-954d-c1b8e1d3a59a
|
|
p:P3350
|
wd:statement/Q423111-b6360fd1-4401-739b-f764-57fe4b2e1c22
|
|
p:P3417
|
wd:statement/Q423111-A79A191E-8BEE-471C-90A3-7E7A040D5094
|
|
p:P3489
|
wd:statement/Q423111-27268CC1-0649-438C-BABA-F0C8262A3D92
|
|
wd:statement/Q423111-FCB2DA24-BBAB-4380-8F62-A2BDBABE56CD
|
|
p:P3636
|
wd:statement/Q423111-876a6ddf-4722-c0a9-3ff8-7d556276c9a4
|
|
p:P3640
|
wd:statement/Q423111-560e720b-4877-1478-d1f4-f93b3d7001c1
|
|
p:P366
|
wd:statement/Q423111-0E14C2CE-4420-4232-9510-F403B9329B02
|
|
p:P373
|
wd:statement/Q423111-9fba9bf5-bcc4-4c81-b2e2-fa5e2b9ee150
|
|
p:P3780
|
wd:statement/Q423111-1E3B5191-C5BD-4169-A60A-8A6C7E7A5B9F
|
|
p:P4235
|
wd:statement/Q423111-6BD5269B-5432-4EBD-B979-E3DEC658210A
|
|
p:P486
|
wd:statement/Q423111-f86e9fc7-4917-aed0-5bbd-15ddddcf8b61
|
|
p:P4964
|
wd:statement/Q423111-A1CC9F41-2715-4038-B54B-EBA44EC85258
|
|
p:P592
|
wd:statement/Q423111-2BEA350A-C98C-4DB9-92E6-0116BC3AC7CD
|
|
p:P595
|
wd:statement/Q423111-A765CABE-6435-4876-9304-8E9D3EF6F797
|
|
p:P6366
|
wd:statement/Q423111-565CE7A3-2CD8-46C1-9C81-2C0F5153CAC8
|
|
p:P638
|
wd:statement/Q423111-2A93FAF5-ABD9-4EF0-AFEA-D685CE96D0A9
|
|
wd:statement/Q423111-4CC9E957-EC60-4109-AF1E-E29E95C0A77D
|
|
wd:statement/Q423111-85EB4470-5799-437A-ABE0-204E82C6CDD7
|
|
p:P646
|
wd:statement/Q423111-AAA9D8DB-448F-4F78-8A52-CC340D46EF5B
|
|
p:P652
|
wd:statement/Q423111-79AF9F06-A9F6-42F3-AE59-5FBACD794941
|
|
p:P661
|
wd:statement/Q423111-BF7395D5-C826-4D5D-90CA-BB89E7E18DDE
|
|
p:P662
|
wd:statement/Q423111-AD0B3754-7FE7-40A2-AAB7-88784817003E
|
|
p:P665
|
wd:statement/Q423111-D1D5E27F-AB30-4384-8515-7F55AAF1C61B
|
|
p:P672
|
wd:statement/Q423111-52c4868b-45f3-4f47-6d80-69463a99269e
|
|
wd:statement/Q423111-78d8e332-4526-28f4-d676-06fc43b49e5f
|
|
wd:statement/Q423111-bf2be402-4e66-378f-31e8-011608bcdb10
|
|
p:P683
|
wd:statement/Q423111-2CBEDC4F-06D1-4AED-927F-3E7DDCD88CD8
|
|
p:P715
|
wd:statement/Q423111-E623B973-521B-4E33-933B-ACEC5221965B
|
|
p:P769
|
wd:statement/Q423111-1CE2BB43-1C0D-44CD-BBB9-90D87D0F7016
|
|
wd:statement/Q423111-CBC9C371-93A0-4FCD-B3F1-D673545D4543
|
|
wd:statement/Q423111-D4189F5C-B62A-448D-8935-780AB50147BE
|
|
p:P7830
|
wd:statement/Q423111-0C2A5A11-BD76-4103-BAF1-5B57D6987F85
|
|
p:P8026
|
wd:statement/Q423111-BD3282EA-B1BA-431B-8CC5-9773F798F380
|
|
p:P8494
|
wd:statement/Q423111-6B47CA8E-3D1F-404B-9EFD-A01060544840
|
|
p:P9272
|
wd:statement/Q423111-514EF588-CABC-4B95-98DA-682D722DB99B
|
|
p:direct-normalized/P1617
|
<http://www.bbc.co.uk/things/513b52df-f7fb-4032-9537-4d0e25ce26f0#id>
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000183250>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/D000077484>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1229517>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2776131300>
|
|
p:direct-normalized/P638
|
<https://rdf.wwpdb.org/pdb/3OG7>
|
|
<https://rdf.wwpdb.org/pdb/4RZV>
|
|
<https://rdf.wwpdb.org/pdb/5HES>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/24747352>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42611257>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D09996>
|
|
p:direct-normalized/P672
|
<http://id.nlm.nih.gov/mesh/D02.065.884.919>
|
|
<http://id.nlm.nih.gov/mesh/D02.886.590.700.919>
|
|
<http://id.nlm.nih.gov/mesh/D03.633.100.473.936>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_63637>
|
|
wdt:P10245
|
"a612009"
|
|
wdt:P10283
|
"C2776131300"
|
|
wdt:P11089
|
"649459"
|
|
wdt:P11143
|
"Vemurafenib"
|
|
wdt:P11198
|
"4185"
|
|
wdt:P11199
|
"PD003414"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Vemurafenib%20structure.svg>
|
|
wdt:P129
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
wdt:P1579
|
"12833468"
|
|
wdt:P1617
|
"513b52df-f7fb-4032-9537-4d0e25ce26f0"
|
|
wdt:P2057
|
"HMDB0259779"
|
|
wdt:P2062
|
"8143"
|
|
wdt:P2067
|
489.073^^xsd:decimal
|
|
wdt:P2115
|
"N0000183250"
|
|
wdt:P2175
|
Erdheim-Chester disease
|
|
melanoma
|
|
metastatic melanoma
|
|
skin cancer
|
|
hairy cell leukemia
|
|
wdt:P2275
|
"vemurafenib"@en
|
|
wdt:P231
|
"918504-65-1"
|
|
wdt:P232
|
"850-250-7"
|
|
wdt:P233
|
"CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F"
|
|
wdt:P234
|
"InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)"
|
|
wdt:P235
|
"GPXBXXGIAQBQNI-UHFFFAOYSA-N"
|
|
wdt:P2566
|
"100.287.801"
|
|
wdt:P267
|
"L01XE15"
|
|
wdt:P274
|
"C₂₃H₁₈ClF₂N₃O₃S"
|
|
wdt:P279
|
chemical compound
|
|
wdt:P2868
|
antineoplastic
|
|
enzyme inhibitor
|
|
xenobiotic-transporting ATPase inhibitor
|
|
protein kinase inhibitors
|
|
wdt:P2877
|
"298931"
|
|
wdt:P2892
|
"C3192263"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID50238710"
|
|
wdt:P3345
|
"1147220"
|
|
wdt:P3350
|
"9286"
|
|
wdt:P3417
|
"Vemurafenib"
|
|
wdt:P3489
|
US pregnancy category D
|
|
Australian pregnancy category D
|
|
wdt:P3636
|
"032"
|
|
wdt:P3640
|
"50242-090"
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Vemurafenib"
|
|
wdt:P3780
|
Zelboraf
|
|
wdt:P4235
|
"vemurafenib"
|
|
wdt:P486
|
"D000077484"
|
|
wdt:P4964
|
"splash10-0006-0024900000-4911e6c7ad52fd2c2896"
|
|
wdt:P592
|
"CHEMBL1229517"
|
|
wdt:P595
|
"5893"
|
|
wdt:P6366
|
"2776131300"
|
|
wdt:P638
|
"3OG7"
|
|
"4RZV"
|
|
"5HES"
|
|
wdt:P646
|
"/m/0hqvq1s"
|
|
wdt:P652
|
"207SMY3FQT"
|
|
wdt:P661
|
"24747352"
|
|
wdt:P662
|
"42611257"
|
|
wdt:P665
|
"D09996"
|
|
wdt:P672
|
"D02.065.884.919"
|
|
"D02.886.590.700.919"
|
|
"D03.633.100.473.936"
|
|
wdt:P683
|
"63637"
|
|
wdt:P715
|
"DB08881"
|
|
wdt:P769
|
efavirenz
|
|
theophylline monohydrate
|
|
fosphenytoin
|
|
wdt:P7830
|
"Vemurafenib"
|
|
wdt:P8026
|
LiverTox toxicity likelihood category E*
|
|
wdt:P8494
|
"DTXCID00161201"
|
|
wdt:P9272
|
"57657"
|